Dexmedetomidine and clonidine induce long-lasting activation of the respiratory rhythm generator of neonatal mice: Possible implication for critical care

Respiratory Physiology and Neurobiology

Volumn 180, Issue 1, 2012, Pages 132-140

  Voituron, Nicolas ^a,c   Hilaire, Gérard ^a   Quintin, Luc ^b  

^a CNRS   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ PARIS 13   (France)

Author keywords

Alpha 2 adrenoceptor agonists; Benzodiazepine; Critical care unit; Midazolam; Neonatal mice; Respiratory rhythm generator

Indexed keywords

CLONIDINE; DEXMEDETOMIDINE; MIDAZOLAM; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; GENERATOR; IN VITRO STUDY; INTENSIVE CARE; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RESPIRATION CENTER; RESPIRATORY BURST; TREATMENT OUTCOME;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; ANIMALS, NEWBORN; CLONIDINE; DEXMEDETOMIDINE; MICE; RESPIRATION; RESPIRATORY CENTER;

EID: 83555178371     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2011.11.003     Document Type: Article

References (65)

1. Aghajanian G., Wang Y. Common alpha 2- and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices. Neuropharmacology 1987, 26:793-799.
2. Akada S., Takeda S., Yoshida Y., Nakazato K., Mori M., Hongo T., Tanaka K., Sakamoto A. The efficacy of dexmedetomidine in patients with noninvasive ventilation: a preliminary study. Anesth. Analg. 2008, 107:167-170.
3. Bach K.B., Mitchell G.S. Hypercapnia-induced long-term depression of respiratory activity requires alpha2-adrenergic receptors. J. Appl. Physiol. 1998, 84:2099-2105.
4. Bailey P.L., Sperry R.J., Johnson G.K., Eldridge S.J., East K.A., East T.D., Pace N.L., Stanley T.H. Respiratory effects of clonidine alone and combined with morphine in humans. Anesthesiology 1991, 74:43-48.
5. Baker-Herman T., Mitchell G. Determinants of frequency long-term facilitation following acute intermittent hypoxia in vagotomized rats. Respir. Physiol. Neurobiol. 2008, 162:8-17.
6. Barton K.P., Munoz R., Morell V.O., Chrysostomou C. Dexmedetomidine as the primary sedative during invasive procedures in infants and toddlers with congenital heart disease. Pediatr. Crit. Care Med. 2008, 9:612-615.
7. Belleville J.P., Ward D.S., Bloor B.C., Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992, 77:1125-1133.
8. Benhamou D., Veillette Y., Narchi P., Ecoffey C. Ventilatory effects of premedication with clonidine. Anesth. Analg. 1991, 73:799-803.
9. Bhana N., Goa K.L., McClellan K.J. Dexmedetomidine. Drugs 2000, 59:263-268.
10. Berends A., Luiten P., Nyakas C. A review of the neuroprotective properties of the 5-HT1A receptor agonist repinotan HCl (BAYx3702) in ischemic stroke. CNS Drug Rev. 2005, 11:379-402.
11. Bolme P., Corrodi H., Fuxe K., Hokfelt T., Lidbrink P., Goldstein M. Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine. Eur. J. Pharmacol. 1974, 28:89-94.
12. Bousquet P., Feldman J., Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 1984, 230:232-236.
13. Bousquet P., Greney H., Bruban V., Schann S., Ehrhardt J., Monassier L., Feldman J. I(1) imidazoline receptors involved in cardiovascular regulation: where are we and where are we going?. Ann. N. Y. Acad. Sci. 2003, 1009:228-233.
14. De Vos H., Bricca G., De Keyser J., De Backer J.P., Bousquet P., Vauquelin G. Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha-2-adrenoceptors in the human central nervous system. Neuroscience 1994, 59:589-598.
15. +-channels in LTD. Eur. J. Neurosci. 2003, 17:1411-1424.
16. Doi A., Ramirez J. Neuromodulation and the orchestration of the respiratory rhythm. Respir. Physiol. Neurobiol. 2008, 164:96-104.
17. Ernsberger P., Meeley M., Reis D. An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla. Brain Res. 1988, 441:309-318.
18. Errchidi S., Monteau R., Hilaire G. Noradrenergic modulation of the medullary respiratory rhythm generator in the newborn rat: an in vitro study. J. Physiol. 1991, 443:477-498.
19. Feldman J., Mitchell G., Nattie E. Breathing: rhythmicity, plasticity, chemosensitivity. Annu. Rev. Neurosci. 2003, 26:239-266.
20. Feldman J., Neverova N., Saywell S. Modulation of hypoglossal motoneuron excitability by intracellular signal transduction cascades. Respir. Physiol. Neurobiol. 2005, 47:131-143.
21. Ghignone M., Quintin L., Duke P.C., Kehler C.H., Calvillo O. Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation. Anesthesiology 1986, 64:36-42.
22. Guyenet P. Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites?. Am. J. Physiol. 1997, 273:R1580-R1584.
23. Hilaire G., Viemari J.C., Coulon P., Simonneau M., Bevengut M. Modulation of the respiratory rhythm generator by the pontine noradrenergic A5 and A6 groups in rodents. Respir. Physiol. Neurobiol. 2004, 143:187-197.
24. Hilaire G., Voituron N., Menuet C., Ichiyama R.M., Subramanian H.H., Dutschmann M. The role of serotonin in respiratory function and dysfunction. Respir. Physiol. Neurobiol. 2010, 174:76-88.
25. Issa F.G. Effect of clonidine in obstructive sleep apnea. Am. Rev. Respir. Dis. 1992, 145:435-439.
26. Jaber S., Petrof B.J., Jung B., Chanques G., Berthet J.P., Rabuel C., Bouyabrine H., Courouble P., Koechlin-Ramonatxo C., Sebbane M., Similowski T., Scheuermann V., Mebazaa A., Capdevila X., Mornet D., Mercier J., Lacampagne A., Philips A., Matecki S. Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am. J. Respir. Crit. Care Med. 2011, 183:364-371.
27. Kinkead R., Bach K.B., Johnson S.M., Hodgeman B.A., Mitchell G.S. Plasticity in respiratory motor control: intermittent hypoxia and hypercapnia activate opposing serotonergic and noradrenergic modulatory systems. Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 2001, 130:207-218.
28. Koroglu A., Demirbilek S., Teksan H., Sagir O., But A.K., Ersoy M.O. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br. J. Anaesth. 2005, 94:821-824.
29. Lahdesmaki J., Sallinen J., MacDonald E., Sirviö J., Scheinin M. Alpha2-adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the alpha2A-adrenoceptor subtype. Neuropharmacology 2003, 44:882-892.
30. Liatsi D., Tsapas B., Pampori S., Tsagourias M., Pneumatikos I., Matamis D. Respiratory, metabolic and hemodynamic effects of clonidine in ventilated patients presenting with withdrawal syndrome. Intensive Care Med. 2009, 35:275-281.
31. Lang B., Li H., Kang J., Li Y. Alpha-2 adrenoceptor mediating the facilitatory effect of norepinephrine on the glycine response in the spinal dorsal horn neuron of the rat. Life Sci. 2003, 73:893-905.
32. Lubisch N., Roskos R., Berkenbosch J.W. Dexmedetomidine for procedural sedation in children with autism and other behavior disorders. Pediatr. Neurol. 2009, 41:88-94.
33. Leino T., Viitamaa T., Haapalinna A., Lehtimäki J., Virtanen R. Pharmacological profile of intrathecal fadolmidine, a alpha2-adrenoceptor agonist, in rodent models. Naunyn. Schmiedebergs Arch. Pharmacol. 2009, 380:539-550.
34. Lim E., Tan C., Jay T., Dawe G. Locus coeruleus stimulation and noradrenergic modulation of hippocampo-prefrontal cortex long-term potentiation. Int. J. Neuropsychopharmacol. 2010, 13:1219-1231.
35. MacFarlane P., Mitchell G. Episodic spinal serotonin receptor activation elicits long-lasting phrenic motor facilitation by an NADPH oxidase-dependent mechanism. J. Physiol. 2009, 587:5469-5481.
36. Manzke T., Niebert M., Koch U., Caley A., Vogelgesang S., Hülsmann S., Ponimaskin E., Müller U., Smart T., Harvey R., Richter D. Serotonin receptor 1A-modulated phosphorylation of glycine receptor α3 controls breathing in mice. J. Clin. Invest. 2010, 120:4118-4128.
37. Manzke T., Dutschmann M., Schlaf G., Mörschel M., Koch U., Ponimaskin E., Bidon O., Lalley P., Richter D. Serotonin targets inhibitory synapses to induce modulation of network functions. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2009, 364:2589-2602.
38. Marley E. Central effects of clonidine 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in fowls. Br. J. Pharmacol. 1975, 55:459-473.
39. Metz G., Nebel B. Clonidine in severe alcohol withdrawal delirium. Fortschr. Med. 1983, 101:1260-1264.
40. Miyazaki S., Uchida S., Mukai J., Nishihara K. Clonidine effects on all-night human sleep: opposite action of low- and medium-dose clonidine on human NREM-REM sleep proportion. Psychiatry Clin. Neurosci. 2004, 58:138-144.
41. Mondaca M., Hernández A., Pérez H., Valladares L., Sierralta W., Fernández V., Soto-Moyano R. Alpha2-adrenoceptor modulation of long-term potentiation elicited in vivo in rat occipital cortex. Brain Res. 2004, 1021:292-296.
42. Newman-Tancredi A., Nicolas J.P., Audinot V., Gavaudan S., Verrièle L., Touzard M., Chaput C., Richard N., Millan M.J. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors. Naunyn. Schmiedebergs Arch. Pharmacol. 1998, 358:197-206.
43. Olkkola K.T., Ahonen J. Midazolam and other benzodiazepines. Handb. Exp. Pharmacol. 2008, 182:335-360.
44. Ooi R., Pattison J., Feldman S.A. The effects of intravenous clonidine on ventilation. Anaesthesia 1991, 46:632-633.
45. Pawlik M.T., Hansen E., Waldhauser D., Selig C., Kuehnel T.S. Clonidine premedication in patients with sleep apnea syndrome: a randomized, double-blind, placebo-controlled study. Anesth. Analg. 2005, 101:1374-1380.
46. Penon C., Ecoffey C., Cohen S.E. Ventilatory response to carbon dioxide after epidural clonidine injection. Anesth. Analg. 1991, 72:761-764.
47. Pichot, C., Ghignone, M., Quintin, L., 2011. Dexmedetomidine and clonidine: from second- to first-line sedative agents in the critical care setting? J. Intensive Care Med., in press.
48. Putensen C., Zech S., Wrigge H., Zinserling J., Stuber F., Von Spiegel T., Mutz N. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am. J. Respir. Crit. Care Med. 2001, 164:43-49.
49. Quintin L., Viale J.P., Annat G., Hoen J.P., Butin E., Cottet-Emard J.M., Levron J.C., Bussery D., Motin J. Oxygen uptake after major abdominal surgery: effect of clonidine. Anesthesiology 1991, 74:236-241.
50. Riker R.R., Shehabi Y., Bokesch P.M., Ceraso D., Wisemandle W., Koura F., Whitten P., Margolis B.D., Byrne D.W., Ely E.W., Rocha M.G. Dexmedetomidine vs. midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009, 301:489-499.
51. Roberge R.J., Kimball E.T., Rossi J., Warren J. Clonidine and sleep apnea syndrome interaction: antagonism with yohimbine. J. Emerg. Med. 1998, 16:727-730.
52. Ruokonen E., Parviainen I., Jakob S.M., Nunes S., Kaukonen M., Shepherd S.T., Sarapohja T., Bratty J.R., Takala J. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med. 2009, 35:282-290.
53. Suzue T. Respiratory rhythm generation in the in vitro brain stem-spinal cord preparation of the neonatal rat. J. Physiol. 1984, 354:173-183.
54. Takahashi H., Nishikawa T., Mizutani T., Handa F. Oral clonidine premedication decreases energy expenditure in human volunteers. Can. J. Anaesth. 1997, 44:268-272.
55. Takamatsu I., Iwase A., Ozaki M., Kazama T., Wada K., Sekiguchi M. Dexmedetomidine reduces long-term potentiation in mouse hippocampus. Anesthesiology 2008, 108:94-102.
56. Thomas A.J., Erokwu B.O., Yamamoto B.K., Ernsberger P., Bishara O., Strohl K.P. Alterations in respiratory behavior, brain neurochemistry and receptor density induced by pharmacologic suppression of sleep in the neonatal period. Brain Res. Dev. Brain Res. 2000, 120:181-189.
57. Valic M., Pecotic R., Pavlinac I., Valic Z., Peros K., Dogas Z. Microinjection of methysergide into the raphe nucleus attenuated phrenic long-term facilitation in rats. Exp. Brain Res. 2010, 202:583-589.
58. Viemari J.C., Bevengut M., Burnet H., Coulon P., Pequignot J.M., Tiveron M.C., Hilaire G. Phox2a gene, A6 neurons, and noradrenaline are essential for development of normal respiratory rhythm in mice. J. Neurosci. 2004, 24:928-937.
59. Viemari J.C., Burnet H., Bevengut M., Hilaire G. Perinatal maturation of the mouse respiratory rhythm-generator: in vivo and in vitro studies. Eur. J. Neurosci. 2003, 17:1233-1244.
60. Viemari J.C., Maussion G., Bevengut M., Burnet H., Pequignot J.M., Nepote V., Pachnis V., Simonneau M., Hilaire G. Ret deficiency in mice impairs the development of A5 and A6 neurons and the functional maturation of the respiratory rhythm. Eur. J. Neurosci. 2005, 22:2403-2412.
61. Voituron N., Shvarev Y., Menuet C., Bevengut M., Fasano C., Vigneault E., El Mestikawi S., Hilaire G. Fluoxetine treatment abolishes the in vitro respiratory response to acidosis in neonatal mice. PLoS One 2010, 5:e13644.
62. Voituron N., Hilaire G. The benzodiazepine Midazolam mitigates the breathing defects of Mecp2-deficient mice. Respir. Physiol. Neurobiol. 2011, 177:56-60.
63. Wei X.Y., Liu J.P., Zhao C.H., Ju G., Wong-Riley M.T., Liu Y.Y. Expressions of 5-HT/5-HT(2A) receptors and phospho-protein kinase C theta in the pre-Botzinger complex in normal and chronic intermittent hypoxic rats. Neuroscience 2010, 168:61-73.
64. Wittmeier S., Song G., Duffin J., Poon C.S. Pacemakers handshake synchronization mechanism of mammalian respiratory rhythmogenesis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:18000-18005.
65. Zanella S., Roux J.C., Viemari J.C., Hilaire G. Possible modulation of the mouse respiratory rhythm generator by A1/C1 neurones. Respir. Physiol. Neurobiol. 2006, 153:126-138.